Industry
Its emergence in the respiratory health sector represents a paradigm shift, offering promising avenues for innovation and investment.
The study revealed that MS-20 dramatically improved treatment outcomes, tripling the objective response rate (ORR) to 75% when combined with Keytruda.
A significant milestone for both microbiome research and neurodegenerative diseases.
A Bill & Melinda Gates Foundation strategic investment to tackle bacterial vaginosis and improve maternal and neonatal health outcomes worldwide.
Industry
Sponsored by
Biofarma Group has launched an innovative project in collaboration with the Department of Surgery, Endocrinology and Gastroenterology of the University of Naples ‘Federico II’, the Centro Sperimentale del Latte (CSL)…
Three-year collaboration to pioneer new insights in microbial sciences and health applications.
New microbiome based therapy demonstrates safety and potential benefits for liver cirrhosis and mental health.
October 2024 saw notable activity in mergers, acquisitions, and strategic investments within the biotech and life sciences industries.
In the session's conclusion, CCNFSDU agreed to maintain the status quo for the next three to five years rather than start to work on new guidelines.
A symphony of microbiome insights: from early infancy to advanced age, the microbiome orchestrates critical processes that affect our health.
